Table: begin end state 1 31 cytoplasmic 32 53 transmembrane 54 58 non-cytoplasmic 59 84 transmembrane 85 117 cytoplasmic 118 143 transmembrane 144 150 non-cytoplasmic 151 168 transmembrane 169 179 cytoplasmic 180 201 transmembrane 202 224 non-cytoplasmic 225 243 transmembrane 244 254 cytoplasmic 255 278 transmembrane 279 300 non-cytoplasmic 301 330 transmembrane 331 350 cytoplasmic 351 372 transmembrane 373 376 non-cytoplasmic 377 399 transmembrane 400 419 cytoplasmic 420 435 transmembrane 436 440 non-cytoplasmic 441 459 transmembrane 460 470 cytoplasmic 471 491 transmembrane 492 497 non-cytoplasmic
Input: >Pf6N2E2_1517 MATHLQGTEPVIPTVTPHPLAGSLRKVEPRRLSLSLLIALVVGSMIGSGIFSLPQNMAAS AGAGAILIGWLITGVGMLSLALVYQTLSNRQPELDNGVFAYARALGGEFLGFNSAWGYWI SAWIGNVSYLVILFAALSYFFPVFGEGNNKAAIVGASVVLWALHWMILRGMRTAAKANAL TTIAKVVPLLLFIGLVIAAFSKDTFMVDFWGTPALGSTLDQVKSTMLVTVWVFIGIEGAN VFSARAAERADVGRATVIGFILTLMLLIAVSLLSLGILRQPELAALKNPSMAGVLEAVAG PWGAVLISIGLIVSVGGALLAWTLLAAESVFTPAKEKVMPRLLATENQHGAPANALWITN GCIQLFLLLTLYSSASYLALISLATSMILLPYLFSGLYALKMTWQGQTYAGHRGLQLRDM AIAVVATGYCVWLLYAAGPRYMLLSALLYAPGSLIYLSAQRARTGRALTGFGWGLLLVIW AAAIFAGWMLWSGQLTL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server